According to our (Global Info Research) latest study, the global Single-chamber Temporary External Pacemaker market size was valued at US$ 53.47 million in 2025 and is forecast to a readjusted size of US$ 78.44 million by 2032 with a CAGR of 5.6% during review period.
A single-chamber temporary external pacemaker is a battery-powered external pulse generator used for short-term cardiac pacing support in a monitored clinical environment. It is connected to a temporary endocardial or epicardial pacing lead through a patient cable and delivers pacing pulses to either the atrium or the ventricle through one pacing channel. The device is typically used for temporary atrial or ventricular pacing in cases such as complete heart block, symptomatic bradycardia, sick sinus syndrome, peri-procedural bradyarrhythmia, support before permanent pacemaker implantation, support during pacemaker replacement, post-cardiac-surgery pacing and interventional cardiology procedures requiring temporary pacing. A typical product provides rate, output, pulse width and sensitivity settings, synchronous and asynchronous pacing modes, pacing and sensing indicators, low-battery alarms, lead connection monitoring, defibrillation protection and protection against accidental parameter changes. This study focuses on single-chamber external temporary pacemaker pulse generators and standard system configurations, rather than implantable pacemakers, pacing leads, patient cables or dual-chamber external pacemakers.
In 2025, the global production volume of single-chamber external temporary pacemakers is projected to reach 12,760 units, with an average price of $4,073 per unit and an average gross margin of 48.6%.
Based on our research, the single-chamber temporary external pacemaker market is a small but clinically important segment within cardiac rhythm management. Its proper boundary is the external temporary pacemaker pulse generator, not the entire pacemaker market. Implantable pacemakers are designed for long-term therapy, leadless pacemakers are implanted intracardiac devices, and transcutaneous pacing modules are generally part of emergency defibrillator-monitor systems. In contrast, a single-chamber temporary external pacemaker is connected to temporary pacing leads and provides short-term atrial or ventricular pacing through one channel. Official product information for Medtronic 53401 and OSYPKA PACE 101 describes these devices as temporary external single-chamber pacemakers used with pacing lead systems and supporting common single-chamber pacing modes such as AAI, VVI, AOO and VOO.
From a supply perspective, the number of true global manufacturers is limited. This is not because the market has been under-researched, but because the product is a regulated, low-volume, safety-critical hospital device with relatively long replacement cycles. Medtronic and BIOTRONIK have strong installed bases and brand recognition in mature hospital systems. OSYPKA, Livetec, FIAB and Galix represent specialist suppliers in external pacing and cardiac stimulation. Shree Pacetronix provides an India-based manufacturing route, BIOSENSOR serves the Brazilian market with the BioRitmo MP20B, and Shenzhen Lifetech Cardio Medical Electronics has become the most visible Chinese domestic supplier, with both 8301 and 6108 temporary pacemaker products disclosed on its official website.
Demand is driven by hospital readiness rather than by consumable-like procedure turnover. These devices are purchased for emergency departments, ICUs, cardiac surgery units, catheterization laboratories, electrophysiology labs and structural heart programs, where temporary pacing is required for bradyarrhythmia management, perioperative support, permanent pacemaker replacement, or procedural backup. Single-chamber systems remain attractive because they are relatively simple, quick to set up and cost-effective for basic atrial or ventricular pacing. However, their growth is partially constrained by dual-chamber external pacemakers in more complex post-operative or hemodynamic management situations, and by procedure-specific systems in TAVR or transcatheter valve interventions. Solo Pace’s cleared SoloPace Control system illustrates how procedure-oriented temporary pacing workflows may create a new adjacent segment rather than simply replacing conventional single-chamber devices.
From a technology perspective, innovation is incremental but meaningful. The main directions include clearer user interfaces, reduced risk of accidental setting changes, stronger battery and backup power design, defibrillation protection, better lead-connection security, easier cleaning and disinfection, and integration of pacing-system analysis functions. Medtronic emphasizes constant-current output and long service life, Livetec highlights touchscreen control and patient/bed fixation, and Shenzhen Lifetech Cardio Medical Electronics positions the 8301 as combining pacing and analysis functions. Over the medium term, this market is expected to grow moderately, with competition centered on clinical safety, regulatory access, service capability, hospital trust and regional localization rather than aggressive capacity expansion.
This report is a detailed and comprehensive analysis for global Single-chamber Temporary External Pacemaker market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Single-chamber Temporary External Pacemaker market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Single-chamber Temporary External Pacemaker market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Single-chamber Temporary External Pacemaker market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Single-chamber Temporary External Pacemaker market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Single-chamber Temporary External Pacemaker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Single-chamber Temporary External Pacemaker market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic plc, BIOTRONIK SE & Co. KG, OSYPKA Medical GmbH, livetec Ingenieurbüro GmbH, FIAB SpA, Solo Pace Inc., Shree Pacetronix Ltd., Galix Biomedical Instrumentation, Inc., BIOSENSOR Indústria e Comércio Ltda., Shenzhen Lifetech Cardio Medical Electronics Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Single-chamber Temporary External Pacemaker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single-chamber Atrial Temporary Pacemaker
Single-chamber Ventricular Temporary Pacemaker
Single-channel Atrial/Ventricular Selectable Pacemaker
Market segment by Pacing Mode
Demand Pacing Mode
Asynchronous Pacing Mode
AAI/VVI Selectable Mode
AOO/VOO Selectable Mode
Rapid Atrial Pacing Mode
Market segment by Application
Emergency Department
Intensive Care Unit
Cardiac Operating Room
Catheterization Laboratory
Electrophysiology Laboratory
Other
Major players covered
Medtronic plc
BIOTRONIK SE & Co. KG
OSYPKA Medical GmbH
livetec Ingenieurbüro GmbH
FIAB SpA
Solo Pace Inc.
Shree Pacetronix Ltd.
Galix Biomedical Instrumentation, Inc.
BIOSENSOR Indústria e Comércio Ltda.
Shenzhen Lifetech Cardio Medical Electronics Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Single-chamber Temporary External Pacemaker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Single-chamber Temporary External Pacemaker, with price, sales quantity, revenue, and global market share of Single-chamber Temporary External Pacemaker from 2021 to 2026.
Chapter 3, the Single-chamber Temporary External Pacemaker competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Single-chamber Temporary External Pacemaker breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Single-chamber Temporary External Pacemaker market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Single-chamber Temporary External Pacemaker.
Chapter 14 and 15, to describe Single-chamber Temporary External Pacemaker sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Single-chamber Temporary External Pacemaker. Industry analysis & Market Report on Single-chamber Temporary External Pacemaker is a syndicated market report, published as Global Single-chamber Temporary External Pacemaker Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Single-chamber Temporary External Pacemaker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.